Vialwirebiotech, curated
November 21, 2026, 8:08 AM
November 5, 2026
- 8:00 AM · BioWorld8:00 AMSuzhou Puhe Biopharma synthesizes new MAT2A inhibitors — BioWorld
- 8:00 AM · BioWorld8:00 AMKimia collaborates with Cstone to advance KT-721 into clinic — BioWorld
- 8:00 AM · BioWorld8:00 AMSepterna selects Graves’ disease candidate — BioWorld
- 8:00 AM · BioWorld8:00 AMLink Biologics completes IND-enabling program for LB-001 — BioWorld
- 8:00 AM · BioWorld8:00 AMSeagen identifies new TFRC-targeting antibody-drug conjugates — BioWorld
- 8:00 AM · BioWorld
- 8:00 AM · BioWorld8:00 AMHenlius’ IL1RAP-targeted antibody cleared for clinic — BioWorld
- 8:00 AM · BioWorld8:00 AMExegenesis Bio presents SMA gene therapy EXG-201 — BioWorld
- 8:00 AM · BioWorld8:00 AMGENC-231 improves renal function in preclinical CKD — BioWorld
- 8:00 AM · BioWorld8:00 AMBlueprint Medicines patents new CDK4-targeting PROTACs — BioWorld
- 8:00 AM · BioWorld
- 8:00 AM · BioWorld
- 7:52 AM · BioPharma Dive7:52 AMT-Therapeutics reloads with a $133M megaround for bispecifics — BioPharma Dive
- 7:33 AM · STAT News7:33 AMSTAT+: Revolution’s pancreatic cancer drug has stunning commercial debut — STAT News
- 6:51 AM · Drug Discovery World6:51 AMUQ selected by US government to develop RNA medicines — Drug Discovery World
- 6:30 AM · STAT News6:30 AMSTAT+: A closer look at ProMis Neurosciences and its Alzheimer’s drug — STAT News
- 5:36 AM · Pharmaceutical Technology5:36 AMEvommune signs $1.1bn licence deal with Hinova for EVO570 — Pharmaceutical Technology
- 4:16 AM · Pharmaceutical Technology4:16 AMPharmatrophiX and Circular partner on neurodegenerative drugs — Pharmaceutical Technology
November 4, 2026
- 5:51 PM · Bloomberg — Technology5:51 PMIsomorphic Labs in Talks for About $5 Billion in Funding — Bloomberg — Technology
- 12:00 PM · Pharmaceutical Technology12:00 PMMSD’s non-oncology sales set to double as Keytruda faces patent cliff — Pharmaceutical Technology
- 11:13 AM · BioPharma Dive11:13 AMNovo gets much-needed lift as Wegovy pill tops Wall Street forecasts — BioPharma Dive
- 11:00 AM · BioWorld11:00 AMPost-Tezspire, winds of change blowing in asthma? — BioWorld
- 11:00 AM · BioWorld11:00 AMNurix sinks as Sanofi drops oral STAT6 degrader from 2019 deal — BioWorld
- 9:46 AM · STAT News9:46 AMSTAT+: Ultragenyx cuts staff after another study fails — STAT News
- 8:00 AM · BioWorld8:00 AMSelective GPC3 targeting and radiotherapeutic activity of HL-7037 — BioWorld
- 8:00 AM · BioWorld
- 8:00 AM · BioWorld8:00 AMADCT-241, an ADC targeting PSMA for metastatic prostate cancer — BioWorld
- 8:00 AM · BioWorld8:00 AMScohia reports findings with SCO-940 for obesity — BioWorld
- 8:00 AM · BioWorld8:00 AMKinoxis’ compounds show promise for neuropathic pain — BioWorld
- 8:00 AM · BioWorld8:00 AMAN2 Therapeutics advances ENPP1 inhibitor for hypophosphatasia — BioWorld
- 7:30 AM · STAT News
- 7:30 AM · Drug Discovery World7:30 AMALLOX closes $10.5m financing to scale allosteric discovery platform — Drug Discovery World
- 6:39 AM · Pharmaceutical Technology6:39 AMBoehringer signs oncology deal with Sino Biopharm worth up to $7.4bn — Pharmaceutical Technology
- 6:36 AM · Pharmaceutical Technology6:36 AMAbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera — Pharmaceutical Technology
- 6:28 AM · Drug Discovery World6:28 AMFDA clears Phase II study of VT-7208 in chronic spontaneous urticaria — Drug Discovery World
- 5:00 AM · Pharmaceutical Technology5:00 AMGEBRO and Spektus sign collaboration for ActraFlex — Pharmaceutical Technology
- 4:39 AM · Pharmaceutical Technology4:39 AMFDA to review uniQure’s BLA for Huntington’s gene therapy — Pharmaceutical Technology
- 4:00 AM · Drug Discovery World4:00 AMGerman hubs selected for BII cardiometabolic research initiative — Drug Discovery World
November 3, 2026
- 3:53 PM · STAT News
- 11:34 AM · Drug Discovery World11:34 AMAlligator Bioscience sells CD40 agonist antibody to Biossil — Drug Discovery World
- 11:23 AM · Pharmaceutical Technology11:23 AMFDA calls for stronger potency upkeep in CGT manufacturing — Pharmaceutical Technology
- 11:00 AM · BioWorld11:00 AMAstellas bets $1.34B on Audax approach to taming IL-12 — BioWorld
- 11:00 AM · BioWorld11:00 AMCOINS Act could upend China biotech deals, as Korea eyes opening — BioWorld
- 11:00 AM · BioWorld11:00 AMFresenius taps Wuxi Biologics for up to 37 biosimilars — BioWorld
- 9:26 AM · Pharmaceutical Executive9:26 AM<![CDATA[Novartis Exits BrainTransporter Deal with BioArctic 14 Months After Signing]]> — Pharmaceutical Executive
- 9:17 AM · Pharmaceutical Executive9:17 AM<![CDATA[Teva Licenses U.S. Rights to Infliximab, Etanercept Biosimilars]]> — Pharmaceutical Executive
- 8:48 AM · PharmaVoice8:48 AMLilly’s R&D whirlwind — what the large pharma has taken in and what it’s dropped — PharmaVoice
- 8:26 AM · FT — Pharmaceuticals8:26 AMPfizer raises outlook on back of demand for non-Covid drugs — FT — Pharmaceuticals